dr. Elien Gevaert
No current affiliation with UGent
- ORCID iD
-
0000-0002-0992-3085
Show
Sort by
-
Mepolizumab and benralizumab reduce eosinophilic inflammation in nasal polyposis, do neutrophils take over?
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2, Supplement S). p.AB161-AB161 -
A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps
-
An underestimated predictive role for Type 2 inflammation in CRSsNP
-
Biologics for chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Unravelling the expression of interleukin-9 in chronic rhinosinusitis : a possible role for Staphylococcus aureus
-
Type 2 inflammation in chronic rhinosinusitis without nasal polyps : another relevant endotype
-
Charcot-Leyden crystals promote neutrophilic inflammation in patients with nasal polyposis
-
Differentiating eosinophil and neutrophil inflammation in chronic rhinosinusitis with and without nasal polyps
-
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
-
Staphylococcus aureus controls interleukin-5 release in upper airway inflammation